Oncology Biorepository Trials

Multiomics blood tests for cancer screening represent a cutting-edge approach in early detection and prevention. By analyzing various biological markers in the blood, such as DNA, RNA, proteins, and metabolites, these tests offer a comprehensive assessment of an individual’s cancer risk.

Hightower leads the way in leveraging advanced multiomics methodologies to pioneer blood-based screening for multiple cancers. By detecting cancers at their earliest stages, we aim to revolutionize cancer screening and treatment, ultimately improving patient outcomes and reducing mortality rates associated with the disease.

With our commitment to innovation, Hightower Clinical aims to reshape the landscape of cancer screening and treatment options, ushering in a new era of effective screening strategies.

The Advanced Precision Observational Lung Living Outcomes (APOLLO) study focuses on advancing precision medicine in lung cancer research. This groundbreaking initiative aims to gather comprehensive data on lung cancer patient’s molecular and clinical characteristics to optimize treatment outcomes.

Hightower’s approach prioritizes the inclusion of smokers in the study population, recognizing the significant impact of smoking on lung cancer development and progression. By analyzing a diverse range of patient profiles, including smokers, the study seeks to uncover novel insights into lung cancer biology. The study aims to offer personalized treatment strategies for individuals suffering from lung cancer.